U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Sold by Sei Investments Co.

Sei Investments Co. cut its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 14.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 69,675 shares of the company’s stock after selling 11,762 shares during the quarter. Sei Investments Co.’s holdings in U.S. Physical Therapy were worth $6,181,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of USPH. Copeland Capital Management LLC raised its position in U.S. Physical Therapy by 9.5% during the 4th quarter. Copeland Capital Management LLC now owns 839,356 shares of the company’s stock worth $74,459,000 after buying an additional 72,715 shares during the last quarter. State Street Corp increased its stake in shares of U.S. Physical Therapy by 17.5% during the third quarter. State Street Corp now owns 667,868 shares of the company’s stock worth $56,522,000 after acquiring an additional 99,244 shares during the period. Southernsun Asset Management LLC raised its holdings in U.S. Physical Therapy by 10.5% during the third quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company’s stock worth $46,302,000 after purchasing an additional 52,062 shares in the last quarter. Geode Capital Management LLC raised its holdings in U.S. Physical Therapy by 1.3% during the third quarter. Geode Capital Management LLC now owns 343,073 shares of the company’s stock worth $29,040,000 after purchasing an additional 4,477 shares in the last quarter. Finally, Bahl & Gaynor Inc. lifted its position in U.S. Physical Therapy by 135.4% in the fourth quarter. Bahl & Gaynor Inc. now owns 260,125 shares of the company’s stock valued at $23,076,000 after purchasing an additional 149,622 shares during the period.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on USPH. JPMorgan Chase & Co. cut their target price on U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating for the company in a research note on Wednesday, March 19th. Bank of America raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and raised their target price for the company from $100.00 to $115.00 in a report on Monday, December 16th. JMP Securities started coverage on shares of U.S. Physical Therapy in a research note on Monday, December 16th. They set an “outperform” rating and a $113.00 price target on the stock. Barrington Research reduced their price objective on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating for the company in a research note on Friday, February 28th. Finally, StockNews.com lowered shares of U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $109.00.

U.S. Physical Therapy Price Performance

Shares of NYSE USPH opened at $72.43 on Tuesday. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. The company’s 50-day moving average price is $82.93 and its 200 day moving average price is $86.52. U.S. Physical Therapy, Inc. has a 52 week low of $69.99 and a 52 week high of $113.63. The stock has a market cap of $1.10 billion, a price-to-earnings ratio of 77.05, a PEG ratio of 3.54 and a beta of 1.51.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing the consensus estimate of $0.69 by ($0.04). U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The business had revenue of $180.45 million during the quarter, compared to analyst estimates of $173.10 million. As a group, research analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be given a $0.45 dividend. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.44. This represents a $1.80 annualized dividend and a dividend yield of 2.49%. The ex-dividend date of this dividend is Friday, March 14th. U.S. Physical Therapy’s dividend payout ratio is currently 97.83%.

Insider Activity at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 1,730 shares of the company’s stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $82.11, for a total transaction of $142,050.30. Following the transaction, the chief operating officer now owns 7,168 shares of the company’s stock, valued at approximately $588,564.48. This represents a 19.44 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.